Has Jusdan Griffith received payments from drug or device companies?

Yes. Drug and device makers reported $5,818 in general payments to Jusdan Griffith across 351 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jusdan Griffith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jusdan Griffith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jusdan Griffith

Psychiatric/Mental Health · Johnstown, PANPI 1114642600

Payments from drug & device makers

$5,818in general payments, 2019–2025

Across 351 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
Teva Pharmaceuticals USA, Inc.$728
Otsuka America Pharmaceutical, Inc.$597
Alkermes, Inc.$324
Lundbeck LLC$193
plus $414 from 5 others

What the payments were for

Food & beverage$5,77199%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	175	$2,071
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	51	$1,491
Teva Pharmaceuticals USA, Inc.	41	$728
Otsuka America Pharmaceutical, Inc.	34	$597
Alkermes, Inc.	18	$324
Lundbeck LLC	11	$193
Axsome Therapeutics, Inc.	9	$173
E.r. Squibb & Sons, L.L.C.	6	$135
Vanda Pharmaceuticals Inc.	3	$51
Corium, LLC	2	$28
Neurocrine Biosciences, Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CAPLYTA$625
UZEDY$125
AUSTEDO$113

How this compares

$5,818 in reported general payments places this provider in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	26	$37,749
Invega SustennaPaliperidone Palmitate	13	$31,791
CaplytaLumateperone Tosylate	17	$27,523
Ramelteon	14	$1,932
Bupropion XlBupropion Hcl	105	$1,637
Buspirone Hcl	115	$1,252
Dexmethylphenidate Hcl ErDexmethylphenidate Hcl	12	$1,060
Hydroxyzine Pamoate	67	$846
Duloxetine Hcl	69	$827
Aripiprazole	45	$744
Venlafaxine Hcl ErVenlafaxine Hcl	75	$668
Gabapentin	35	$640
Clonazepam	88	$565
Fluvoxamine Maleate	16	$491
Sertraline Hcl	53	$468

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$2,071	$37,74926 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$1,491	$27,52317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Johnstown

Tammy DunnJohnstown$14K
Roxanne AltemusJohnstown$8K
Kimberly GarciaAllentown$573K
Cortney SmithWashington$227K
Britney KeplerPittsburgh$158K
Kirstyn KamegBethel Park$136K
Anna DipietroDowningtown$131K
Deena MasciocchiLanghorne$71K
Joseph GagnonChesterbrook$64K
Michelle CohenWashington$62K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →